Author (Year) | Platelet Count | Bone marrow findings | Period between vaccination and occurrence of ITP (days) | |
---|---|---|---|---|
Before vaccine | After vaccine | |||
Tishler et al. (2006) | NR | 3,000/mm3 | hypercellularity with many megakaryocytes and no infiltration of foreign cells | 14 |
Mamori et al. (2008) | 164āĆā103/µL | 5āĆā103/ml | NR | 7 |
Kelton et al. (1981) | Reported to be normal | 20,000 /µL | NR | 14 |
Wan Jamaludin et al. (2018) | 203āĆā109/L | 3āĆā109/L | hypo-normocellularity, adequate megakaryocytopoiesis without lymphomatous relapse or dysplasia supportive of ITP | 7 |
Shlamovitz et al. (2013) | NR | less than 5 k/mL | hypercellular marrow with erythroid and megakaryocytic hyperplasia. There was a mild to moderate left shift of the red cell precursors and megakaryocytes | 4 |
Ikegame et al. (2006) | 180āĆā109/l | 3810 38āĆā109/l and 10āĆā109/l on days 14 and 17 | Bone marrow examination revealed hyperplastic megakaryopoiesis, with no evidence of relapse | 14 |
Almohammadi et al. (2019) | 210,000ā267,000/µL | 0/µL | NR | 2 |
Hamiel et al. (2016) | NR | 17 000/µL | NR | 7 |
Mantadakis et al. (2010) | NR | 11,000/UL | NR | 26 |
Nagasaki et al. (2016) | 184,000/šL | 39,000/šL | normocellular; the megakaryocyte count was 56/šL | 28 |
Ohta et al. (2022) | 251,000/šL | 5,000/šL | Bone marrow was normocellular. | 35 |